In late 2020, Roth et al published findings on the real-world use of deep transcranial magnetic stimulation (Deep TMS) to relieve symptoms of obsessive-compulsive disorder (OCD). Deep TMS was FDA cleared for OCD in 2018, as well as major depressive disorder (MDD) and smoking cessation. In general, their results demonstrated a continuous reduction in Yale Brown Obsessive Compulsive Scale (Y-BOCS) scores as Deep TMS sessions increased.
